CN118812488A - 美丽海绵内酯、其类似物及其用途 - Google Patents

美丽海绵内酯、其类似物及其用途 Download PDF

Info

Publication number
CN118812488A
CN118812488A CN202410801829.5A CN202410801829A CN118812488A CN 118812488 A CN118812488 A CN 118812488A CN 202410801829 A CN202410801829 A CN 202410801829A CN 118812488 A CN118812488 A CN 118812488A
Authority
CN
China
Prior art keywords
compound
formula
alkyl
mmol
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410801829.5A
Other languages
English (en)
Chinese (zh)
Inventor
阿伦·K·高希
卢克·A·卡塞克特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of CN118812488A publication Critical patent/CN118812488A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
CN202410801829.5A 2016-05-27 2017-05-26 美丽海绵内酯、其类似物及其用途 Pending CN118812488A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662342601P 2016-05-27 2016-05-27
US62/342,601 2016-05-27
CN201780032805.6A CN109195666A (zh) 2016-05-27 2017-05-26 美丽海绵内酯、其类似物及其用途
PCT/US2017/034760 WO2017205791A1 (en) 2016-05-27 2017-05-26 Callyspongiolide, analogs thereof and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201780032805.6A Division CN109195666A (zh) 2016-05-27 2017-05-26 美丽海绵内酯、其类似物及其用途

Publications (1)

Publication Number Publication Date
CN118812488A true CN118812488A (zh) 2024-10-22

Family

ID=60411563

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202410801829.5A Pending CN118812488A (zh) 2016-05-27 2017-05-26 美丽海绵内酯、其类似物及其用途
CN201780032805.6A Pending CN109195666A (zh) 2016-05-27 2017-05-26 美丽海绵内酯、其类似物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201780032805.6A Pending CN109195666A (zh) 2016-05-27 2017-05-26 美丽海绵内酯、其类似物及其用途

Country Status (7)

Country Link
US (1) US10875836B2 (enExample)
EP (1) EP3463579B1 (enExample)
JP (3) JP7502846B2 (enExample)
KR (1) KR102481799B1 (enExample)
CN (2) CN118812488A (enExample)
CA (1) CA3025178A1 (enExample)
WO (1) WO2017205791A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118812488A (zh) 2016-05-27 2024-10-22 普渡研究基金会 美丽海绵内酯、其类似物及其用途
CN119585437A (zh) * 2022-07-29 2025-03-07 上海皓元医药股份有限公司 一种艾日布林中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104177209B (zh) * 2014-08-05 2015-12-02 太原理工大学 一种芳基末端炔的制备方法
CN105777702B (zh) * 2016-03-31 2018-02-13 北京大学深圳研究生院 Callyspongiolide立体异构体的合成及抗癌应用
CN118812488A (zh) 2016-05-27 2024-10-22 普渡研究基金会 美丽海绵内酯、其类似物及其用途

Also Published As

Publication number Publication date
JP2022120170A (ja) 2022-08-17
EP3463579A4 (en) 2019-11-27
EP3463579B1 (en) 2025-07-16
EP3463579A1 (en) 2019-04-10
WO2017205791A1 (en) 2017-11-30
JP2024164181A (ja) 2024-11-26
US20190218198A1 (en) 2019-07-18
JP2019517474A (ja) 2019-06-24
CA3025178A1 (en) 2017-11-30
CN109195666A (zh) 2019-01-11
KR102481799B1 (ko) 2022-12-26
KR20190012194A (ko) 2019-02-08
JP7641933B2 (ja) 2025-03-07
JP7502846B2 (ja) 2024-06-19
US10875836B2 (en) 2020-12-29

Similar Documents

Publication Publication Date Title
AU2009331179B2 (en) Novel bicyclic heterocyclic compound
CN111032034B (zh) 螺环化合物及其制造和使用方法
JP2022536845A (ja) Ｐｄ－ｌ１疾患の治療のための化合物
TWI586666B (zh) Tetrahydrocarboline Derivatives (2)
CA2570780C (en) Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
JP2024164181A (ja) カリスポンジオリド、その類似体、およびそれらの使用
UA72611C2 (uk) Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази
US20170088555A1 (en) Hiv-1 protease inhibitors and uses thereof
RU2742770C1 (ru) Производное индола и формамида, способ его получения и применение в медицине
EP4174068A1 (en) Novel compound, and pharmaceutical composition for preventing or treating resistant cancer, comprising same
EP3538090A1 (en) Tricyclic p2-ligand containing potent hiv-protease inhibitors against hiv/aids
CN104583203B (zh) Schweinfurthin类似物
US11230550B2 (en) Macrocyclic HIV-1 protease inhibitors and uses thereof
JP7111722B2 (ja) 抗がん剤およびその調製方法
US20230136594A1 (en) Tricyclic p2-ligand containing potent hiv-protease inhibitors
JP2025539091A (ja) ＨＩＦ－２α阻害剤としてのアリールチオエーテル
HK40006497A (en) Anti-cancer agents and preparation thereof
TW200842126A (en) Taxane compound having azetidine ring structure
CZ20002893A3 (cs) Glukokortikoidně selektivní protizánětlivé látky
HK1162504B (en) Novel bicyclic heterocyclic compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination